Alzheimer's disease, a progressive neurodegenerative disorder, is characterized by significant brain atrophy, particularly in areas responsible for memory and cognition. As the disease advances, neurons shrink and connections between them deteriorate, leading to a noticeable decrease in brain volume. This atrophy primarily affects the hippocampus, crucial for memory formation, and the cerebral cortex, involved in thinking, planning, and language.
The underlying causes of Alzheimer's-related brain atrophy include the buildup of amyloid plaques and tau tangles, which disrupt cellular function and contribute to neuron loss. This structural damage correlates with cognitive decline and manifests as symptoms such as memory loss, confusion, and personality changes. Understanding these changes in brain structure is crucial for developing effective diagnostic tools and treatments aimed at slowing or halting the progression of Alzheimer's disease and related dementias.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States